|
|
|
|
|
非在研适应症- |
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期- |
A Phase 1 Open-Label, First-in-Human Trial of Oral MBQ-167 as Single Agent in Participants With Advanced Breast Cancer
A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of Care (SOC) has failed or has proven intolerable.
100 项与 MBQ PHARMA INC. 相关的临床结果
0 项与 MBQ PHARMA INC. 相关的专利(医药)
100 项与 MBQ PHARMA INC. 相关的药物交易
100 项与 MBQ PHARMA INC. 相关的转化医学